AI Verdict
RYN has stronger fundamentals based on our AI analysis.
RYTM vs RYN Fundamental Comparison
| Metric | RYTM | RYN |
|---|---|---|
| Revenue | $189.8M | $484.5M |
| Net Income | $-196.5M | $474.4M |
| Net Margin | -103.6% | 97.9% |
| ROE | -141.3% | 21.5% |
| ROA | -40.9% | 13.9% |
| Current Ratio | 4.41x | 3.26x |
| Debt/Equity | 0.73x | 0.38x |
| EPS | $-3.11 | $3.03 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RYTM vs RYN: Frequently Asked Questions
Is RYTM or RYN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RYN has stronger fundamentals. RYTM is rated SELL (78% confidence) while RYN is rated BUY (76% confidence). This is not investment advice.
How does RYTM compare to RYN fundamentally?
RHYTHM PHARMACEUTICALS, INC. has ROE of -141.3% vs RAYONIER INC's 21.5%. Net margins are -103.6% vs 97.9% respectively.
Which stock pays higher dividends, RYTM or RYN?
RYTM has a dividend yield of N/A or no dividend while RYN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RYTM or RYN for long term?
For long-term investing, consider that RYTM has SELL rating with 78% confidence, while RYN has BUY rating with 76% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RYTM vs RYN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RYTM vs RYN, the AI consensus favors RYN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.